Skip to content
TrialScanner

NCT00632463

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

Phase 2CompletedADMALead

Registry record

Lead sponsor
ADMA Biologics, Inc.
Conditions
Upper Respiratory Tract Infection; Lower Respiratory Tract Infection
Primary completion
May 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00632463 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00632463: RI-001 in Immunosuppressed... | TrialScanner